
Ahluwalia Contracts Announces FY26 Financial Results and Recommends 35% Dividend
Ahluwalia Contracts (India) Limited announced the financial results for the quarter and full year ended March 31, 2026. The Board of Directors of the company reviewed and approved the audited financial statements for both standalone and consolidated entities.In a key announcement regarding shareholder returns, the Board of Directors recommended a final dividend at a rate of 35% per equity share, translating to Re. 0.70 Paisa per share. This dividend, however, remains subject to the approval of the shareholders at the upcoming Annual General Meeting (AGM) for the financial year ended March 31, 2026.
Financial Performance Highlights
The company released audited financial results for the quarter and the full year ended March 31, 2026, confirming an unmodified opinion from the Independent Auditors, M/s SCV & Co., LLP.The segment results provide a detailed view of the company's performance:
Segment Results (Rs. in Lakhs)
| Particulars | Quarter Ended 31/03/2026 (Audited) | Quarter Ended 31/12/2025 (Un-Audited) | Quarter Ended 31/03/2025 (Audited) | Year Ended 31/03/2026 (Audited) | Year Ended 31/03/2025 (Audited) |
|---|---|---|---|---|---|
| Revenue from Operations | 132,229.87 | 106,072.04 | 121,583.63 | 456,519.81 | 409,862.31 |
| Total Income (tI) | 134,773.92 | 107,592.95 | 123,386.60 | 463,669.67 | 415,399.77 |
| Total Expenses | 123,978.40 | 100,220.29 | 112,212.19 | 427,917.73 | 388,159.55 |
| Net Profit after tax for the period/year | 8,014.06 | 5,401.84 | 8,316.47 | 26,432.16 | 20,151.08 |
| Total Comprehensive Income | 7,973.29 | 5,413.43 | 8,333.45 | 26,391.49 | 20,128.09 |
| EPS (Basic) in Rupees | 8.06 | 12.41 | 39.46 | 30.08 |
For the consolidated view, the total income reached 134,775.93 for the quarter ended March 31, 2026, up from 107,592.95 for the previous quarter, with the full year total income standing at 463,671.68. The consolidated net profit after tax for the period was 26,586.34.
Statement of Assets and Liabilities
The company’s financial standing was also detailed in the Statement of Assets and Liabilities (Standalone and Consolidated).Balance Sheet Snapshot (Rs. in Lakhs)
| Particulars | As at 31/03/2026 (Standalone) | As at 31/03/2025 (Standalone) | As at 31/03/2026 (Consolidated) | As at 31/03/2025 (Consolidated) |
|---|---|---|---|---|
| Total Assets | 426,586.77 | 370,713.12 | 426,485.52 | 370,594.62 |
| Total Equity | 205,996.14 | 180,006.57 | 205,890.37 | 179,844.74 |
| Total Non-Current Liabilities | 52,664.20 | 48,812.49 | 45,696.69 | 52,664.20 |
Corporate and Regulatory Updates
In a related corporate action, the Board of Directors also approved a scheme of amalgamation involving several subsidiaries, including Dipesh Mining Pvt. Ltd., Jiwanjyoti Traders Pvt. Ltd., Paramount Dealcomm Pvt. Ltd., Premsagar Merchants Pvt. Ltd, and Splendor Distributors Pvt. Ltd., with Ahluwalia Contracts (India) Ltd. The amalgamation was approved on a going concern basis.The Board meeting, which concluded on May 30, 2026, considered and approved these items along with the audited financial statements.
AHLUCONT Stock Price Movement
On Friday, Ahluwalia Contracts (India) Limited shares slipped by 3.46% to settle at ₹792. The stock finished the day on a volume of 90,923 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.